DETECTION OF TOXOPROTEIN PRODUCED BY MRSA, MONOCLONAL ANTIBODY AND ITS FRAGMENT, KIT FOR DETECTING TOXOPROTEIN PRODUCED BY MRSA AND HYBRIDOMA CAPABLE OF PRODUCING MONOCLONAL ANTIBODY

Japanese Patent JP2000316574

A

To rapidly and simply detect a toxoprotein with high degree of reliability by using an antibody having the ability to specifically bind to a toxoprotein produced by a methicillin-resistant Staphylococcus aureus(MRSA).

An antibody having the ability to specifically bind to a toxoprotein produced by MRSA such as a monoclonal antibody is used to detect the toxoprotein produced by the MRSA. Furthermore, the monoclonal antibody is preferably specific for leukocidin F which is the toxoprotein produced by the MRSA or is preferably produced by a hybridoma (FERM BP-6669) prepared by cell fusion of an animal cell immunized with the leukocidin F to a cell of a myeloma of the animal, preferably has the ability to specifically bind to the leukocidin F and is preferably labeled with an enzyme, a radioisotope, a fluorescent coloring matter, biotin, etc.

WO/2006/013329	ASSAY DEVICE & METHOD
WO/2023/245800	ANTI-CRYPTOCOCCUS CAPSULAR POLYSACCHARIDE MONOCLONAL ANTIBODY AND USE THEREOF
WO/2021/074291	TCR-INDEPENDENT MOLECULAR IDENTIFICATION OF MUTATION-RELATED AND TUMOR-SPECIFIC T CELLS

NAKANO OSAHISA
KAMATA YOICHI
KAMIO YOSHIKORE
NIWA KAZUHIRO
ONOUCHI TORU
GOTO YUICHI

JP2000059946A

November 21, 2000

March 06, 2000

Click for automatic bibliography generation  

MATSUSHITA SEIKO KK
OSAKA PREFECTURE

G01N33/569; C07K14/31; C07K16/12; C12N5/10; C12N15/02; C12P21/02; C12P21/08; G01N33/543; G01N33/577; (IPC1-7): C12N15/02; C07K16/12; C12N5/10; C12P21/08; G01N33/569; G01N33/577

Fumio Iwahashi (2 others)

Previous Patent: PREPARATION OF ASCITES USING CELL LINE CAPABLE OF PRODUCING MONOCLONAL ANTIBODY AGAINST α SUBUNIT O...

Next Patent: SCREENING OF ANAPHYLACTIC REPRESSOR